Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Anni Pan, Zhaoyang Wang, Binlong Chen, Wenbing Dai, Hua Zhang, Bing He, Xueqing Wang, Yiguang Wang & Qiang Zhang. (2018) Localized co-delivery of collagenase and trastuzumab by thermosensitive hydrogels for enhanced antitumor efficacy in human breast xenograft. Drug Delivery 25:1, pages 1495-1503.
Read now
Read now
Debra H Josephs, James F Spicer, Panagiotis Karagiannis, Hannah J Gould & Sophia N Karagiannis. (2014) IgE immunotherapy. mAbs 6:1, pages 54-72.
Read now
Read now
Articles from other publishers (33)
Yue Ji, Dingkang Liu, Haichao Zhu, Lichen Bao, Ruilong Chang, Xiangdong Gao & Jun Yin. (2023) Unstructured polypeptides as a versatile drug delivery technology. Acta Biomaterialia 164, pages 74-93.
Crossref
Crossref
Linghui Qian, Xuefen Lin, Xue Gao, Rizwan Ullah Khan, Jia-Yu Liao, Shubo Du, Jingyan Ge, Su Zeng & Shao Q. Yao. (2023) The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics. Chemical Reviews 123:12, pages 7782-7853.
Crossref
Crossref
Thomas Ertveldt, Lien De Beck, Kirsten De Ridder, Hanne Locy, Wout de Mey, Cleo Goyvaerts, Quentin Lecocq, Hannelore Ceuppens, Yannick De Vlaeminck, Robin Maximilian Awad, Marleen Keyaerts, Nick Devoogdt, Matthias D'Huyvetter, Karine Breckpot & Ahmet Krasniqi. (2022) Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177–Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma Model. Molecular Cancer Therapeutics 21:7, pages 1136-1148.
Crossref
Crossref
Sana Arnouk, Timo W.M. De Groof & Jo A. Van Ginderachter. (2022) Imaging and therapeutic targeting of the tumor immune microenvironment with biologics. Advanced Drug Delivery Reviews 184, pages 114239.
Crossref
Crossref
Robin Maximilian Awad, Fien Meeus, Hannelore Ceuppens, Thomas Ertveldt, Heleen Hanssens, Quentin Lecocq, Lukasz Mateusiak, Katty Zeven, Hana Valenta, Timo W.M. De Groof, Yannick De Vlaeminck, Ahmet Krasniqi, Kim De Veirman, Cleo Goyvaerts, Matthias D’Huyvetter, Sophie Hernot, Nick Devoogdt & Karine Breckpot. 2022. New Antibody Formats. New Antibody Formats
143
199
.
Dao Shi, Jiangyuan Zhuang, Zhongxiong Fan, Hai Zhao, Xin Zhang, Guanghao Su, Liya Xie, Dongtao Ge & Zhenqing Hou. (2021) Self-targeting nanotherapy based on functionalized graphene oxide for synergistic thermochemotherapy. Journal of Colloid and Interface Science 603, pages 70-84.
Crossref
Crossref
Arghavan Soleimanizadeh, Heiko Dinter & Katharina Schindowski. (2021) Central Nervous System Delivery of Antibodies and Their Single-Domain Antibodies and Variable Fragment Derivatives with Focus on Intranasal Nose to Brain Administration. Antibodies 10:4, pages 47.
Crossref
Crossref
Maricruz Anaya-Ruiz & Martin Perez-Santos. (2021) Small-molecule inhibitor PD-1/PD-L1 interaction for colorectal cancer treatment. Pharmaceutical Patent Analyst 10:6, pages 245-250.
Crossref
Crossref
Qian‐Ni Ye, Yue Wang, Song Shen, Cong‐Fei Xu & Jun Wang. (2021) Biomaterials‐Based Delivery of Therapeutic Antibodies for Cancer Therapy. Advanced Healthcare Materials 10:11.
Crossref
Crossref
Fabrizio Marcucci & Cristiano Rumio. (2021) Depleting Tumor Cells Expressing Immune Checkpoint Ligands—A New Approach to Combat Cancer. Cells 10:4, pages 872.
Crossref
Crossref
Wanatchaporn Arunmanee, Methawee Duangkaew, Pornchanok Taweecheep, Kanokpol Aphicho, Panuwat Lerdvorasap, Jesada Pitchayakorn, Chayada Intasuk, Runglada Jiraratmetacon, Armini Syamsidi, Pithi Chanvorachote, Chatchai Chaotham & Natapol Pornputtapong. (2021) Resurfacing receptor binding domain of Colicin N to enhance its cytotoxic effect on human lung cancer cells. Computational and Structural Biotechnology Journal 19, pages 5225-5234.
Crossref
Crossref
Sepideh Khaleghi, Shahryar Khoshtinat Nikkhoi & Fatemeh Rahbarizadeh. 2021. Cancer Nanotheranostics. Cancer Nanotheranostics
93
123
.
Christophe Lallemand, Rosa Ferrando-Miguel, Michael Auer, Sarah Iglseder, Theresa Czech, Anouk Gaber-Wagener, Franziska Di Pauli, Florian Deisenhammer & Michael G. Tovey. (2020) Quantification of Bevacizumab Activity Following Treatment of Patients With Ovarian Cancer or Glioblastoma. Frontiers in Immunology 11.
Crossref
Crossref
Baptiste Gouyou, Jacopo Millul, Alessandra Villa, Samuele Cazzamalli, Dario Neri & Mattia Matasci. (2020) Sortase-Mediated Site-Specific Modification of Interleukin-2 for the Generation of a Tumor-Targeting Acetazolamide–Cytokine Conjugate. ACS Omega 5:40, pages 26077-26083.
Crossref
Crossref
Kip P. Conner, Siva Charan Devanaboyina, Veena A. Thomas & Dan A. Rock. (2020) The biodistribution of therapeutic proteins: Mechanism, implications for pharmacokinetics, and methods of evaluation. Pharmacology & Therapeutics 212, pages 107574.
Crossref
Crossref
Takuma Yoshikawa, Khanh Quoc Phan, Hiroshi Tagawa, Koichi Sasaki, Haitao Feng, Akihiro Kishimura, Takeshi Mori & Yoshiki Katayama. (2020) Modification of nitric oxide donors onto a monoclonal antibody boosts accumulation in solid tumors. International Journal of Pharmaceutics 583, pages 119352.
Crossref
Crossref
Dobeen Hwang & Christoph Rader. (2020) Site-Specific Antibody–Drug Conjugates in Triple Variable Domain Fab Format. Biomolecules 10:5, pages 764.
Crossref
Crossref
Shie Yin Ng, Anyanee Kamkaew, Nanyan Fu, Chin Siang Kue, Lip Yong Chung, Lik Voon Kiew, Jatuporn Wittayakun, Kevin Burgess & Hong Boon Lee. (2020) Active targeted ligand-aza-BODIPY conjugate for near-infrared photodynamic therapy in melanoma. International Journal of Pharmaceutics 579, pages 119189.
Crossref
Crossref
Fabrizio Marcucci, Carmelo Antonio Caserta, Elisabetta Romeo & Cristiano Rumio. (2019) Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)—Is There Still Room for Optimism?. Frontiers in Oncology 9.
Crossref
Crossref
Matteo Bellone & Sara Caputo. 2019. Cancer Stem Cell Resistance to Targeted Therapy. Cancer Stem Cell Resistance to Targeted Therapy
173
221
.
Angela Rita Elia, Sara Caputo & Matteo Bellone. (2018) Immune Checkpoint-Mediated Interactions Between Cancer and Immune Cells in Prostate Adenocarcinoma and Melanoma. Frontiers in Immunology 9.
Crossref
Crossref
Joanna Macdonald, Justin Henri, Kislay Roy, Emma Hays, Michelle Bauer, Rakesh Veedu, Normand Pouliot & Sarah Shigdar. (2018) EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs. Cancers 10:1, pages 19.
Crossref
Crossref
David Aebisher & Dorota Bartusik. 2018. Design of Nanostructures for Theranostics Applications. Design of Nanostructures for Theranostics Applications
467
491
.
Matteo Bellone & Angela Rita Elia. (2017) Constitutive and acquired mechanisms of resistance to immune checkpoint blockade in human cancer. Cytokine & Growth Factor Reviews 36, pages 17-24.
Crossref
Crossref
Christophe Lallemand, Feifei Liang, Flore Staub, Maud Simansour, Benoit Vallette, Lue Huang, Rosa Ferrando-Miguel & Michael G. Tovey. (2017) A Novel System for the Quantification of the ADCC Activity of Therapeutic Antibodies. Journal of Immunology Research 2017, pages 1-19.
Crossref
Crossref
David Aebisher, Dorota Bartusik & Jacek Tabarkiewicz. (2017) Laser flow cytometry as a tool for the advancement of clinical medicine. Biomedicine & Pharmacotherapy 85, pages 434-443.
Crossref
Crossref
Fuyuan Zhou, Wenxue Wang & Lianqing Liu. (2016) Discrimination of the state of MCF-7 cells by multiple cell mechanics. Discrimination of the state of MCF-7 cells by multiple cell mechanics.
Fabrizio Marcucci, Cristiano Rumio & François Lefoulon. (2016) Anti-Cancer Stem-like Cell Compounds in Clinical Development – An Overview and Critical Appraisal. Frontiers in Oncology 6.
Crossref
Crossref
Fuyuan Zhou, Wenxue Wang, Mi Li & Lianqing Liu. (2015) Force curve classification using independent component analysis and support vector machine. Force curve classification using independent component analysis and support vector machine.
Ye-Jin Kim, Jeomil Bae, Tae-Hwan Shin, Se Hun Kang, Moonkyoung Jeong, Yunho Han, Ji-Ho Park, Seok-Ki Kim & Yong-Sung Kim. (2015) Immunoglobulin Fc-fused, neuropilin-1-specific peptide shows efficient tumor tissue penetration and inhibits tumor growth via anti-angiogenesis. Journal of Controlled Release 216, pages 56-68.
Crossref
Crossref
Fabrizio Marcucci, Matteo Bellone, Carmelo Antonio Caserta & Angelo Corti. (2014) Pushing tumor cells towards a malignant phenotype: Stimuli from the microenvironment, intercellular communications and alternative roads. International Journal of Cancer 135:6, pages 1265-1276.
Crossref
Crossref
Tae-Hwan Shin, Eun-Sil Sung, Ye-Jin Kim, Ki-Su Kim, Se-Ho Kim, Seok-Ki Kim, Young-Don Lee & Yong-Sung Kim. (2014) Enhancement of the Tumor Penetration of Monoclonal Antibody by Fusion of a Neuropilin-Targeting Peptide Improves the Antitumor Efficacy. Molecular Cancer Therapeutics 13:3, pages 651-661.
Crossref
Crossref
Mi Li, Xiubin Xiao, Lianqing Liu, Ning Xi, Yuechao Wang, Zaili Dong & Weijing Zhang. (2013) Nanoscale mapping and organization analysis of target proteins on cancer cells from B-cell lymphoma patients. Experimental Cell Research 319:18, pages 2812-2821.
Crossref
Crossref